Brinter Joins Winston Starts Accelerator, Poised for Accelerated Growth

Brinter Joins Winston Starts Accelerator, Poised for Accelerated Growth

June 30, 2023

Brinter, a biotech company from North Carolina, is thrilled to announce its acceptance into the Winston Starts Accelerator. This collaboration marks a significant milestone for Brinter, as it opens the doors to unparalleled growth opportunities in the Southeastern United States alongside an esteemed cohort of professionals and mentors. Winston Starts, renowned for its commitment to fostering the success of startups, has become an invaluable resource for local entrepreneurs looking to scale their businesses.

We are extremely excited to join the Winston Starts. This partnership will accelerate our growth trajectory and provide us access to top-tier mentors and investors who can guide us through the intricacies of scaling our business.

Tom Alapaattikoski, CEO of Brinter

Stan Parker, President at Winston Starts, has played a pivotal role in Brinter’s journey in North Carolina thus far, connecting the company with essential partners and industry experts. Brinter acknowledges Parker’s invaluable assistance and expresses gratitude for the doors he has opened.

Stan Parker have been instrumental in helping us navigate the startup landscape in North Carolina. Winston Starts support and guidance have already proven invaluable, and we are eager to tap into their expertise to further drive our science and success.

Dr. Matthew Brovold, Science Manager of Brinter

Brinter is an innovative startup poised to revolutionize the implant industry with its 3D bioprinted personalized Bio-implants. By being accepted into the Winston Starts Accelerator and Mentor Program, Brinter gains access to program’s extensive network of mentors, industry experts, and potential investors presents invaluable opportunities for collaboration and growth. The acceptance into the Winston Starts Accelerator and Mentor Program serves as a testament to Brinter’s potential and highlights the company’s commitment to realizing its vision of developing personalized bio-implants.

Learn more: